Acousia Therapeutics raises 10 mln euros
Acousia Therapeutics said May 14 that it raised 10 million euros ($11.9 million) in a Series B round led by LBBW Venture Capital and joined by new investors Creathor Ventures and Bregua Corp. Boehringer Ingelheim Venture Fund (BIVF) and Kreditanstalt für Wiederaufbau also participated in the round. Acousia, of Tubingen, German, is developing therapies for inner ear-related diseases and pathologies.
14 May 2018•3 mins read
